-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-218-osteoporosis-disposition-comments.pdf
April 23, 2019 - How ever,
this statement is based on data from a small phase 2 study that
w as not designed or pow … bone mass after long-term continued,
discontinued, and restarting of therapy: a randomized blinded
phase … In re-evaluating the evidence from this phase 2 trial on
long-term fracture prevention for denosumab … bone mass after long-term continued,
discontinued, and restarting of therapy: a randomized blinded
phase … In re-evaluating the evidence from this phase 2
denosumab trial on long-term fracture prevention for
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND-0653-131114.pdf
June 14, 2013 - populations, interventions, comparators, and outcomes, will
be further developed in the refinement phase
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/antidepressants-update_executive.pdf
December 01, 2011 - antidepressants differ in their efficacy or
effectiveness for preventing relapse (i.e.,
continuation phase … ) or recurrence (i.e., maintenance
phase) when a patient:
• continues the drug they initially responded … ) or recurred
(maintenance phase), do alternative second-
generation antidepressants differ in their … of the 78 possible drug
comparisons of second-generation antidepressants for
the treatment of acute-phase … For
example, for acute-phase MDD we found only 3
effectiveness studies out of 92 head-to-head RCTs.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0263_12-28-2007.pdf
January 01, 2007 - populations,
interventions, comparators, and outcomes, will be further developed in the refinement phase
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0107_05-19-2009.pdf
January 01, 2009 - populations, interventions, comparators, and outcomes, will be further
developed in the refinement phase
-
effectivehealthcare-admin.ahrq.gov/products/labor-nitrous-oxide/research-protocol
December 01, 2019 - Additional discussions with the TEP following the public comment phase were also critical in shaping … The majority of comments received during the public comment phase were judgments regarding the effectiveness … Analytic Framework
Several comments were received during the public comment phase and TEP discussions … criteria developed based on our understanding of the literature developed during the topic refinement phase … Weekly during the review phase of the study, the Project Coordinator will report the number of abstracts
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/psoriasis-chronic_research-protocol.pdf
January 10, 2012 - I (2): complete;
Phase II: complete
Certolizumabpego
l (CDP870)
Cimzia
®
(injectable) … or
metastatic pancreatic cancer, given in combination
with gemcitabine
Currently available;
Phase … active ankylosing
spondylitis in adults
Currently available;
Open-label study in
recruitment phase … † Plaque psoriasis development stage is described by: Phase (number of studies): status (if applicable … † Plaque psoriasis development stage is described by: Phase (number of studies): status (if applicable
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1312.pdf
January 01, 2016 - Results
The table below lists the eight topics for which (1) preliminary phase III data for drugs, at … least
phase II or equivalent data for devices and procedures, or some human data for off-label uses … In March 2013, Intarcia began phase III trials of the ITCA 650/pump system. … This injectable drug competes with other drugs in phase III trials, such as
fluocinolone acetonide … Intarcia presents positive ITCA 650 phase 2 study
results for type 2 diabetes at EASD.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1412.pdf
December 01, 2014 - inclusion are those interventions expected to be within 0–3 years of potential diffusion (e.g., in
phase … Results
The table below lists the single topic for which (1) preliminary phase III data for drugs were … Phase III trials
on which U.S. … Of the 595 subjects, 173 subjects were treated in Phase 3 SBS
studies (134/173 [77%] at the dose of … Phase 3 Gattex (teduglutide) data highlight potential
new treatment for adults with short bowel syndrome
-
effectivehealthcare-admin.ahrq.gov/products/medical-tests-series/overview
August 01, 2019 - Skip to main content
An official website of the Department of Health & Human Services
Careers
Contact Us
Español
FAQs
Effective Health Care Program
Powered by the Evidence-based Practice Centers
…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/diabetes-behavior-programs_disposition-comments.pdf
September 28, 2015 - of intervention following the
intensive intervention phase. … of
these interventions on A1c is usually greater
immediately following the intensive intervention phase … We have meant to use the word support
only for the phase of a program extending the DSME
(hence our … We did not include studies that were only
evaluating the support phase of a program. … maintenance phase of
interventions.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1412.pdf
January 01, 2015 - Results
The table below lists the four topics for which (1) preliminary phase III data for drugs, at … least
phase II or equivalent data for devices and procedures, or some human data for off-label uses … The company reported in October 2014 that two phase III trials (FREEDOM 1 and
FREEDOM 1 high baseline … Available: http://www.intarcia.com/media/press-
releases/2014-oct-1-phase-3.html.
63. … Intarcia CEO to present company progress,
interim phase 3 data, and key milestones at J.P.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/01_-arthritis_potential_high_impact_june_2012.pdf
January 01, 2012 - Results
The table below lists the seven topics for which (1) preliminary phase III or later phase data … Expert comments led to designation of one RA therapy in
phase III development as having high potential … In the most recent phase III trials, tofacitinib was
administered twice daily in 5 and 10 mg doses. … In phase III trials, patients treated with
tofacitinib demonstrated improvements in signs and symptoms … Pfizer's tofacitinib meets endpoints in final
phase III trials.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0161_09-01-2009.pdf
January 01, 2009 - populations, interventions, comparators, and outcomes, will be further developed in the
refinement phase
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0288_03-10-2008.pdf
January 01, 2008 - populations, interventions, comparators, and outcomes, will be further developed in the refinement
phase
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0136_07-21-2009.pdf
January 01, 2009 - populations, interventions, comparators, and outcomes, will
be further developed in the refinement phase
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0456_07-27-2011.pdf
January 01, 2011 - populations, interventions, comparators, and outcomes, will be further
developed in the refinement phase
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0064_11-23-2008.pdf
January 01, 2008 - populations, interventions, comparators, and
outcomes, will be further developed in the refinement phase
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0119_06-17-2009.pdf
January 01, 2009 - populations, interventions, comparators, and outcomes, will be further developed in the
refinement phase
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND-0647-13114.pdf
June 21, 2013 - populations, interventions,
comparators, and outcomes, will be further developed in the refinement phase